<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>AD-23 Bioproductos by Juan Jesús Cruz Maldonado</title>
      <link>https://padlet.com/juanjcm/fewl385y6zfunm6k</link>
      <description>Comparte en este espacio la información que investigaste acerca del bioproducto seleccionado</description>
      <language>en-us</language>
      <pubDate>2023-01-23 18:46:48 UTC</pubDate>
      <lastBuildDate>2023-02-15 21:55:58 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url>https://padlet.net/icons/png/1f52c.png</url>
      </image>
      <item>
         <title>Bioplastic</title>
         <author>a01367715</author>
         <link>https://padlet.com/juanjcm/fewl385y6zfunm6k/wish/2484140570</link>
         <description><![CDATA[<div><strong>Name and classification</strong>: Bioplastic (poly-3-hydroxybutyrate), biomaterial<br><br><strong>Microorganism that produces/synthesizes it: </strong>marine bacterium Pseudodonghicola xiamenensis<br><br><strong>Need(s) to which it responds and/or<br>applications: T</strong>he global demand for bioplastic as a substitute for synthetic plastics has increased due to its nontoxicity, renewability, biocompatibility, and biodegradability. <br><br><em>Mostafa, Y. S., Alrumman, S. A., Alamri, S. A., Otaif, K. A., Mostafa, M. S., &amp; Alfaify, A. M. (2020). Bioplastic (poly-3-hydroxybutyrate) production by the marine bacterium Pseudodonghicola xiamenensis through date syrup valorization and structural assessment of the biopolymer. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-65858-5 <br></em><br>‌</div>]]></description>
         <enclosure url="" />
         <pubDate>2023-02-15 21:36:11 UTC</pubDate>
         <guid>https://padlet.com/juanjcm/fewl385y6zfunm6k/wish/2484140570</guid>
      </item>
      <item>
         <title>Monoclonal antibodies</title>
         <author></author>
         <link>https://padlet.com/juanjcm/fewl385y6zfunm6k/wish/2484144060</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-02-15 21:40:44 UTC</pubDate>
         <guid>https://padlet.com/juanjcm/fewl385y6zfunm6k/wish/2484144060</guid>
      </item>
      <item>
         <title>Invertase</title>
         <author>a01770068</author>
         <link>https://padlet.com/juanjcm/fewl385y6zfunm6k/wish/2484144483</link>
         <description><![CDATA[<div>Andy, Maca y Oli<br>Bees and humans produce invertase naturally. But for commercial production, invertase is sourced mainly from fungi and yeast. Yeast species such as Saccharomyces cerevisiae and Candida utilis are used for commercial production of the invertase enzyme. On the basis of sequence similarity, invertase is classified within family 32 of the glycoside hydrolases, is considered a Biochemical compound. Invertase enzyme converts sucrose or table sugar to the inverted sugar solution. This is used to prevent the crystallization of sugar and used to make sweet, gooey liquid centres and caramel fillings in candies and chocolates.<br><br>Infinita Biotech. (2022, January 5). <em>Infinita Biotech</em>. Infinita Biotech. https://infinitabiotech.com/blog/uses-of-invertase-enzyme/#:~:text=Enzymatic%20Sources%20of%20Invertase,production%20of%20the%20invertase%20enzyme.</div><div>‌</div>]]></description>
         <enclosure url="" />
         <pubDate>2023-02-15 21:41:21 UTC</pubDate>
         <guid>https://padlet.com/juanjcm/fewl385y6zfunm6k/wish/2484144483</guid>
      </item>
      <item>
         <title>Monoclonal antibodies</title>
         <author>a01769664</author>
         <link>https://padlet.com/juanjcm/fewl385y6zfunm6k/wish/2484144701</link>
         <description><![CDATA[<div><strong>1. Name and classification<br></strong>High-affinity monoclonal antibodies<br><br>Biochemical compound<br>* Biopharmaceutical<br><strong><br>2. Microorganism that produces/synthesizes it<br></strong>*B lymphocytes<br><strong><br>3. Need(s) to which it responds and/or<br>applications</strong><br>This strict selection by specific and strong interaction between antigen and antibody enables the efficient production of monoclonal antibodies with high specificity and affinity. It also offers the condensation of sensitized target B lymphocytes to selectively generate hybridoma cells secreting desired monoclonal antibodies. <br><br>Sakashita, K., Tsumoto, K., &amp; Tomita, M. (2022). Advanced hybridoma technology for selective production of high-affinity monoclonal antibodies through B-cell receptors. <em>Journal of Immunological Methods</em>, <em>511</em>, 113384.<br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2023-02-15 21:41:38 UTC</pubDate>
         <guid>https://padlet.com/juanjcm/fewl385y6zfunm6k/wish/2484144701</guid>
      </item>
      <item>
         <title> Vaccines of COVID-19</title>
         <author></author>
         <link>https://padlet.com/juanjcm/fewl385y6zfunm6k/wish/2484146421</link>
         <description><![CDATA[<div>Classification: Biochemical compounds (biopharmaceuticals)<br><br><br></div><ul><li><strong>Messenger RNA (mRNA) vaccine.</strong> This type of vaccine gives your cells instructions for how to make the S protein found on the surface of the COVID-19 virus. After vaccination, your muscle cells begin making the S protein pieces and displaying them on cell surfaces. This causes your body to create antibodies. If you later become infected with the COVID-19 virus, these antibodies will fight the virus.<br>Once the protein pieces are made, the cells break down the instructions and get rid of them. The mRNA in the vaccine doesn’t enter the nucleus of the cell, where DNA is kept. Both the Pfizer-BioNTech and the Moderna COVID-19 vaccines use mRNA.<br><br></li></ul>]]></description>
         <enclosure url="" />
         <pubDate>2023-02-15 21:43:49 UTC</pubDate>
         <guid>https://padlet.com/juanjcm/fewl385y6zfunm6k/wish/2484146421</guid>
      </item>
      <item>
         <title>Biomaterials team 4.</title>
         <author>a013675091</author>
         <link>https://padlet.com/juanjcm/fewl385y6zfunm6k/wish/2484146745</link>
         <description><![CDATA[<div>Artificial ligaments and tendons- Biomaterials<br>It is produced by the combination of fibroblast and synthetic plastics. It responds directly to replace or reinforce an existing ligament, they must function for at least 6 months in ACL reinforcement cases and permanently for replacement cases. They are made of PET knitted in non-deforming and non-warpable chains. </div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1736215426/0513b3f62e4db79934b10d8aeece5794/1_materialssci.jpeg" />
         <pubDate>2023-02-15 21:44:14 UTC</pubDate>
         <guid>https://padlet.com/juanjcm/fewl385y6zfunm6k/wish/2484146745</guid>
      </item>
   </channel>
</rss>
